Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Online First

June 07, 2021

Correspondence
Correspondence on ‘Warfarin use and risk of knee and hip replacements’
Free

Na He, Zhenwei Fang, Xiaotong Li, Suodi Zhai

doi: 10.1136/annrheumdis-2021-220819
Correspondence response
Response to: ‘Correspondence on: ‘Warfarin use and risk of knee and hip replacements’’ by He et al
Free

Priyanka Ballal, Christine Peloquin, Cindy Germaine Boer, Tuhina Neogi

doi: 10.1136/annrheumdis-2021-220855

May 26, 2021

Correspondence
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’
Free

Zhen Gong, Fangjie Zhang

doi: 10.1136/annrheumdis-2021-220494
Correspondence response
Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ by Gong and Zhang and Lin et al
Free

Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Annelies Boonen

doi: 10.1136/annrheumdis-2021-220477
Correspondence
Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’
Free

Tsung-Kun Lin, Lung-Fa Pan, Gwo-Ping Jong

doi: 10.1136/annrheumdis-2021-220453

May 17, 2021

Correspondence response
Response to: ‘Correspondence on ‘Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?’ by Su et al
Free

Xenofon Baraliakos, Adrian Richter, Carsten O Schmidt, Juergen Braun

doi: 10.1136/annrheumdis-2021-220632
Correspondence
Correspondence on ‘Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?’
Free

Chun-Lin Su, Jhih-Wei Chen, James Cheng-Chung Wei

doi: 10.1136/annrheumdis-2021-220567

May 13, 2021

Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al
Free

Kimme L Hyrich, Martin Schäfer, Anja Strangfeld, Loreto Carmona, Laure Gossec, Elsa F Mateus, Saskia Lawson-Tovey, Milena Gianfrancesco, Philip C Robinson, Jinoos Yazdany, Pedro M Machado

doi: 10.1136/annrheumdis-2021-220613
Correspondence
Correspondence on ‘Warfarin use and risk of knee and hip replacements’
Free

Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2021-220580
Correspondence response
Response to: ‘Correspondence on ‘Warfarin use and risk of knee and hip replacements’’ by Cheng and Zhang
Free

Tuhina Neogi, Christine Peloquin, Priyanka Ballal, Cindy Germaine Boer

doi: 10.1136/annrheumdis-2021-220601
Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Free

James Todd Rosenbaum, Michael H Weisman, Cassie Shafer, Elin Aslanyan, Richard A Howard, Kimberly Ogle, Hedley Hamilton, John D Reveille, Kevin L Winthrop, Dongseok Choi

doi: 10.1136/annrheumdis-2021-220588

May 12, 2021

Correspondence
Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’
Free

Desiree Tampe, Peter Korsten, Samy Hakroush, Martin Sebastian Winkler, Björn Tampe

doi: 10.1136/annrheumdis-2021-220382
Correspondence response
Response to: ‘Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’’ by Tampe et al
Free

Marcia A Friedman, Kevin L Winthrop

doi: 10.1136/annrheumdis-2021-220398

April 27, 2021

Correspondence response
Response to: ‘Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’’ by Roongta et al
Free

Veerle F A M Derksen, Diane van der Woude

doi: 10.1136/annrheumdis-2021-220516
Correspondence
Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’
Free

Rashmi Roongta, Arghya Chattopadhyay, Alakendu Ghosh

doi: 10.1136/annrheumdis-2021-220479

April 26, 2021

Correspondence response
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al
Free

Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé

doi: 10.1136/annrheumdis-2021-220474
Correspondence
Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’
Free

Aimilios Kaklamanos, Panagiotis Karamichalos, Panayiotis G Vlachoyiannopoulos, Athanasios G Tzioufas

doi: 10.1136/annrheumdis-2021-220411

April 21, 2021

Correspondence
Correspondence on ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine’
Free

Hercílio Martelli Júnior, Nelson Pereira Marques, Nádia Carolina Teixeira Marques, Edson Gomes de Lucena, Daniella Reis B Martelli, Eduardo A Oliveira

doi: 10.1136/annrheumdis-2021-220410

April 09, 2021

Correspondence
Correspondence on ‘Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study’
Free

Liang En Wee, Edwin Philip Conceicao, Jing Yuan Tan, Julian Thumboo, Indumathi Venkatachalam

doi: 10.1136/annrheumdis-2021-220462

April 02, 2021

Correspondence
Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus’
Free

Ezgi Deniz Batu, Ummusen Kaya Akca, Ozge Basaran, Yelda Bilginer, Seza Ozen

doi: 10.1136/annrheumdis-2021-220246
Correspondence response
Response to: ‘Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus’ by Batu et al
Free

Christina Adamichou, George Bertsias

doi: 10.1136/annrheumdis-2021-220262
Correspondence response
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by de Wolff et al
Free

Renaud Felten, Jacques-Eric Gottenberg

doi: 10.1136/annrheumdis-2021-220220

March 31, 2021

Correspondence
Correspondence on: ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’
Free

Alojzija Hočevar, Aleš Ambrožič, Matija Tomšič

doi: 10.1136/annrheumdis-2021-220290
Correspondence response
Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hocevar et al
Free

Philipp Gauckler, Erica L Bettac, Andreas Kronbichler

doi: 10.1136/annrheumdis-2021-220324

March 24, 2021

Correspondence response
Response to: ‘Correspondence on ‘Statistical review: frequently given comments’’ by Waki et al
Free

Stian Lydersen

doi: 10.1136/annrheumdis-2021-220336
Correspondence
Correspondence on ‘Statistical review: frequently given comments’
Free

Daisuke Waki, Masahiro Banno, Takashi Fujiwara

doi: 10.1136/annrheumdis-2021-220332

March 23, 2021

Correspondence
Correspondence on ‘Factors associated with progression to inflammatory arthritis in first-degree relatives of individuals with RA following autoantibody positive screening in a non-clinical setting’
Free

Marc Scherlinger, Thierry Schaeverbeke

doi: 10.1136/annrheumdis-2021-220345
Correspondence
Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised controlled trial’
Free

Liseth de Wolff, Suzanne Arends, Gwenny M Verstappen, Arjan Vissink, Frans G M Kroese, Hendrika Bootsma

doi: 10.1136/annrheumdis-2021-220198

March 10, 2021

Correspondence response
Response to: ‘Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’’ by Shanoj et al
Free

Kristin M D’Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace

doi: 10.1136/annrheumdis-2021-220166
Correspondence
Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’
Free

Shanoj K C, Sakir Ahmed, Veena Shenoy, Aparna R Menon, Sanjo Saijan, Sageer AS Babu, Padmanabha Shenoy

doi: 10.1136/annrheumdis-2021-220148

March 04, 2021

Correspondence response
Response to: ‘Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’’ by Banday et al
Free

Peter Nash, Josef S Smolen

doi: 10.1136/annrheumdis-2021-219919
Correspondence
Correspondence on ‘Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement’
Free

Aaqib Zaffar Banday, Ankur Kumar Jindal, Surjit Singh

doi: 10.1136/annrheumdis-2021-219890

March 03, 2021

Correspondence
Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’
Free

Zaid Jibri, Ummugulsum Gazel, Dilek Solmaz, Gizem Ayan, Jacob Karsh, Sibel Zehra Aydin, Marcos Sampaio

doi: 10.1136/annrheumdis-2021-220008
Correspondence response
Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Charles
Free

Josef S Smolen

doi: 10.1136/annrheumdis-2021-220164
Correspondence response
Response to: ‘Correspondence on ‘MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group’’ by Jibri et al
Free

Walter P Maksymowych, Robert GW Lambert, Mikkel Østergaard, Xenofon Baraliakos

doi: 10.1136/annrheumdis-2021-220078

March 01, 2021

Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Free

Ben Mulhearn

doi: 10.1136/annrheumdis-2021-220099
Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Mulhearn et al
Free

Martin Schäfer, Anja Strangfeld, Kimme L Hyrich, Loreto Carmona, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Laure Gossec, Philip C Robinson, Jinoos Yazdany, Pedro M Machado

doi: 10.1136/annrheumdis-2021-220134

February 23, 2021

Correspondence response
Response to: ‘Correspondence on ‘Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment’’ by Pamuk and Hasni
Free

Lyna Kamintsky, Steven D Beyea, John D Fisk, Javeria A Hashmi, Antonina Omisade, Cynthia Calkin, Tim Bardouille, Chris Bowen, Maher Quraan, Arnold Mitnitski, Kara Matheson, Alon Friedman, John G Hanly

doi: 10.1136/annrheumdis-2021-220057
Correspondence
Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’
Free

Rui Gao, Lang Qin

doi: 10.1136/annrheumdis-2021-220092
Correspondence response
Response to: ‘Correspondence on ‘EULAR recommendations for the management of antiphospholipid syndrome in adults’’ by Gao and Qin
Free

Maria G Tektonidou, Angela Tincani, Michael M Ward

doi: 10.1136/annrheumdis-2021-220116
Correspondence
Correspondence on ‘Blood–brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment’
Free

Omer Nuri Pamuk, Sarfaraz Hasni

doi: 10.1136/annrheumdis-2021-220031
Correspondence response
Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’’ by Zheng
Free

Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Tjeerd P van Staa, Annelies Boonen, Frank de Vries

doi: 10.1136/annrheumdis-2021-219856

February 22, 2021

Correspondence response
Response to: ‘Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’’ by Ruscitti et al
Free

Joshua F Baker, Bryant R England, Ted R Mikuls

doi: 10.1136/annrheumdis-2021-220114
Correspondence
Correspondence on ‘Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis’
Free

Piero Ruscitti, Giorgio Sesti, Paola Cipriani, Roberto Gerli, Roberto Giacomelli

doi: 10.1136/annrheumdis-2021-220047

February 18, 2021

Correspondence
Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’
Free

Laurent Arnaud, Hervé Devilliers

doi: 10.1136/annrheumdis-2021-220037
Correspondence response
Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’ by Arnaud and Devilliers
Free

Pedro M Machado, Martin Schäfer, Anja Strangfeld, Laure Gossec, Milena Gianfrancesco, Saskia Lawson-Tovey, Elsa F Mateus, Loreto Carmona, Kimme L Hyrich, Philip C Robinson, Jinoos Yazdany

doi: 10.1136/annrheumdis-2021-220058

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

June 23, 2021

June 22, 2021

June 10, 2021

June 07, 2021

May 26, 2021

May 17, 2021

May 13, 2021

May 12, 2021

April 27, 2021

April 26, 2021

April 21, 2021

April 09, 2021

April 02, 2021

March 31, 2021

March 24, 2021

March 23, 2021

March 10, 2021

March 04, 2021

March 03, 2021

March 01, 2021

February 23, 2021

February 22, 2021

February 18, 2021

Pages